Phoenix Venture Partners LP Announces Strategic Partnership with Pfizer Inc.

San Mateo, California — March 5, 2012 — Phoenix Venture Partners LLC (PVP) announced today that it has entered into a strategic partnership with Pfizer Inc., through its corporate venture capital arm, Pfizer Venture Investments, which aims to identify breakthrough materials science innovations. Pfizer will join a consortium of global corporations, across diverse industries, with a shared interest in fostering and supporting materials science innovation. Specific terms of the partnership were not disclosed.

Dr. Zach Jonasson, General Partner at PVP, commented, “My partners and I are excited to be working with Pfizer. We see a strong synergy with Pfizer’s diverse interests in materials science technologies. The partnership is already off to a great start.”

Nobi Kambe, General Partner at PVP, added, “As a global leader and innovator in the pharmaceutical industry, Pfizer is an ideal partner for PVP. We are proud to be working with the experienced teams within Pfizer, notably Pharmaceutical Sciences and Pfizer Global Supply, who continually explore the latest in technological innovation.”

Dr. Barbara Dalton, Vice President of Venture Capital at Pfizer, stated, “We are pleased, both as a financial and strategic investor, to be working alongside Phoenix Venture Partners.  Their innovative business model and commitment to this critical, but underserved area represents an attractive opportunity for Pfizer to support and access material science innovation alongside leaders from other industries involved in the consortium.”

As part of the strategic partnership, Jennifer Friel Goldstein, Pfizer Venture Investments, has joined the Phoenix Venture Partners Advisory Committee.


About Phoenix Venture Partners

Phoenix Venture Partners (PVP) is a leading venture capital firm that invests in and partners with entrepreneurs to commercialize breakthrough materials science innovations. PVP’s team has a track record of founding, building and investing in successful materials science start-ups. The firm’s investment strategy is flexible and predicated on assisting entrepreneurs with customer and supply chain partnerships, business development, as well as strategic and operational support. PVP also collaborates with a select set of forward-looking global corporations on business development and innovation interests. PVP is based in Silicon Valley with satellite offices in Singapore and Cambridge, MA.

Najia Saidi